A new eBook from electronic publisher Quicklook Books aims to give outsiders a broad overview of the veterinary profession.
According to author, veterinary surgeon Bob Lehner, Quicklook@Vets offers readers the opportunity to get below the surface of the veterinary working practice and gain insight into the profession, without becoming 'bogged down' in complicated medical terminology.
He said: "The veterinary world, although considered by many to be an enthralling subject, is accessible to very few people. Texts are, more often than not, written for veterinary graduates instead of the general public.
"In Quicklook@Vets, I wanted to explore all the aspects of this exciting subject in a clear, coherent manner, without unnecessary jargon, to enable anyone to read and learn about the captivating world of veterinary practice."
As a vet with over 35 years of experience, Bob Lehner worked with a wide range of animals and has experience in commercial deer farming, working with zoo animals and as a veterinary surgeon for the pharmaceutical industry. Now retired, Bob Lehner works part-time in practice, as an inspector for the RCVS Practise Standards Scheme and work with an animal charity in Botswana neutering feral village dogs.
The book is available for download here
Dechra Veterinary Products has published a range of case studies to support its new campaign focused on the diagnosis and treatment of otitis externa.
The studies have been written by Referral Dermatologist Sue Paterson MA, VetMB, DVD, DipECVD, MRCVS, RCVS European Specialist in Veterinary Dermatology and Peter Forsythe BVM&S, DVD, MRCVS, RVCS Specialist in Veterinary Dermatology.
Developed as part of the Time to Change campaign, the real-life examples feature a series of problems and solutions associated with otitis, supported by clear images and photomicrographs.
Larry King, Senior Brand Manager, Dechra Veterinary Products, said: "We have created a range of in-depth case study materials for use by vets and vet nurses which will support identification and management of otitis externa, one of the more frequent conditions seen in general practice.
"As veterinary professionals are aware, otitis is common and can be challenging to diagnose and treat. These studies address individual cases and demonstrate how the Dechra dermatology range can be used effectively.
"Topics covered in the case studies include the types of otitis presented by each animal, how individual organisms were identified using cytology and how long treatment was continued."
The case studies, which feature Malassezia, staphylococcal and Proteus infections, also discuss the underlying causes and steps taken after treatment with Canaural and various ear cleaners.
The Time to Change campaign has been launched to support a best practice approach to otitis which includes the identification of the organisms causing infection through cytology, support the selection of the correct treatment and assist with educating clients on how to apply and use products correctly.
For further information visit www.dechra.com/timetochange. The website also highlights the benefits of Dechra Veterinary Products' range of topical treatments and ear flushes, including Canaural, CleanAural, CerumAurual, TrizAural and MalAceticAural.
BSAVA PetSavers is funding a research project at the University of Liverpool designed to help vets and owners provide the best care for senior and geriatric dogs.
In the first part of the study, veterinary professionals were interviewed about the services currently provided to senior dogs and their owners regarding preventative healthcare, treatment, and advice.
Owners were interviewed about their experiences of living with and accessing veterinary care for senior dogs.
The results of these interviews were then used to develop the online survey which researchers now need vets to take part in, to validate the interview findings in a quantitative way.
Dr Carri Westgarth said: “The veterinary survey focuses on the perceived barriers to care for senior dogs, end-of-life care including quality-of-life, and the potential design of the BSAVA PetSavers guidance tool.
"We would be grateful if any veterinary professional could take a few minutes from their day to help us with this project.”
The survey should take around 20–25 minutes to complete.
Survey participants will also have the opportunity to win an Amazon voucher.
The survey can be accessed here: https://bit.ly/PetsaversOAPVetSurvey.
The Registrar and Secretary of the Royal College of Veterinary Surgeons, Jane Hern, has announced that she will be standing down at the end of the year.
After 15 years in the job, Jane says she has been pleased to oversee a number of significant reforms and new initiatives in her time leading the organisation, but has decided that it is time to move on and pursue other interests.
The College says it is now embarking on a comprehensive review of its governance, committee and management structures, during which the Officers and Council will consider how best the executive should be led in future.
Jane said: "I have greatly enjoyed my time with the College and the Trust. Working with a profession held in such high regard by the public has been a real pleasure. I wish veterinary surgeons, veterinary nurses and all my colleagues all the very best for the future."
The President, Dr Jerry Davies said: "The Royal College has been very fortunate in having the benefit of Jane's wisdom and guidance for so many years, and we wish her every success in the future."
The Royal College of Veterinary Surgeons Charitable Trust is offering a bursary for one delegate to attend the Veterinary Biomedical and Pharma Sciences (VBMPS) Congress on 15 and 16 October 2012 at the ICC in Birmingham.
Members of the RCVS with an interest in 'one health' are eligible to apply. Entrants are asked to explain, in no more than 400 words, their interest in the concept of one health and why they should be granted a bursary.
Entrants should also demonstrate how they would disseminate their learning from the event to the wider veterinary community.
Entries should be sent to grants@rcvstrust.org.uk by Monday 3 September 2012, and the winner will be notified within two weeks.
The bursary winner will be given a delegate pass worth £175 for entry to the conference and admission to all scientific sessions. Reasonable transport costs and accommodation will be reimbursed.
Further details are available at http://trust.rcvs.org.uk/grants-and-collaborations
Research carried out by the Kennel Club to coincide with the start of Open for Dogs Week has found that 40% of British people think dogs are a happy alternative to having children.
One reason for this is perhaps because 25% of respondents said that a dog would fit more easily with their lifestyle than a child. Or maybe it's partly because 25% said that whilst their children always come first, they prefer to do things with their dog.
In addition, 80% said their dog is attentive and loving when out and about, compared to only 50% who said the same is true of their other half.
However, despite the central place that dogs hold in their owners' hearts, the Kennel Club says many people experience difficulty taking their dogs out and about, particularly to restaurants. In the survey, 40% said that they have problems finding a place where their dog is welcome while they eat, and almost 50% said that they'd like to see a wider variety of restaurants open their doors to dogs.
Caroline Kisko, Kennel Club Secretary, said: "This research proves what a well loved member of the family a dog is. Given how much we love spending time with our dogs, it is surprising that there are still so many businesses that refuse to allow dogs in their premises, but there is a real appetite for this to change.
"The Kennel Club's Open for Dogs website lists more than 26,000 places throughout the UK and Europe that allow dogs inside, which makes it easier for dog owners to plan days out and holidays without having to leave their dogs behind.
"During Open for Dogs Week we are asking businesses, whether it is a restaurant, hotel, pub, shop or office, to trial a dog friendly policy. There are more than eight million dogs in the UK, so those that get involved will be appealing to a massive customer base, which can only be a good thing in tough economic times." The Kennel Club's Open for Dogs Week runs from 20-26 August 2012 and businesses and public places are encouraged to adopt a dog friendly policy for well behaved dogs.
To nominate your favourite dog friendly venue or town for the Kennel Club's Open for Dogs Awards, visit www.openfordogs.org.uk. The deadline for nominations is 31st August.
Royal Canin has announced it is to launch Catom, a piece of software developed to help educate cat owners during veterinary consultations, at this year's London Vet Show.
Initially, the software will be available for PC and Mac, with iPad and Android versions coming by the end of the year.
You can can find out more by visiting Royal Canin's stand at the London Vet Show, where the company says it will have a large touch-screen TV displaying the software, along with laptop demos running throughout the exhibition.
The WSAVA has launched a petition to save ketamine from being placed under international scheduling, a move which the association says would prevent those who most need the drug having access to it.
The proposal to schedule ketamine is likely to be considered at the 59th UN Convention on Narcotic Drugs (CND) taking place between now and the 22nd March 2016 in Vienna.
Apparently, the proposal stems from a widespread misconception that ketamine is only a recreational drug. WSAVA argues that it is in fact the only anaesthetic suitable for use in middle and low income countries, and it also has particular value 'in the field' for trauma, traffic and sporting injuries. It is also the common and often only product used for sterilization initiatives - instrumental in the feral dog/cat population and critical for the control of zoonotic diseases, such as rabies.
To sign the petition, visit: http://chn.ge/1RFSou6. You can also share the petition post on facebook: https://www.facebook.com/WSAVA/.
Talking to The Guardian, Hamaseh said: "This has really shocked me. We just discovered at the airport when we went to check in. I want people to know that this is not just happening to refugees. I am a graduate and I have a PhD. It has happened to a person who is working and who pays tax."
Hamaseh, who thought she'd have to find thousands of pounds to pay for an alternative flight home via another country, was quickly saved by a crowdfunding appeal by Women for Independence, which raised over £6000 in a matter of hours. The charity says it is donating everything in excess of the £2600 needed to get Hamaseh home to the Scottish Refugee Council.
Professor Anton Muscatelli, Principal of the University of Glasgow, said: "When I became aware on Saturday evening that one of our postgraduate veterinary students, Dr Hamaseh Tayari, was being prevented from travelling back from a holiday in Costa Rica through the United States and on to Glasgow I was both concerned and appalled. Concerned for the safety and well being of a young woman who, through no fault of her own, was stranded in Central America. Appalled because the reason for her predicament was not because she had done something wrong. Not because she was a danger to the security of the United States. But simply because she holds an Iranian passport."
He added: "Having spoken with Hamaseh I have been hugely impressed at how she is coping with the nightmare situation in which she finds herself. But I have been impressed too by the huge outpouring of support that has been shown across Scotland and the UK, particularly on twitter and through direct emails that have come in to the University from people who are outraged and want to help. All of this, I know, has greatly touched and heartened Hamaseh. I think it also confirms what we all like to believe is true. In this country we value individuals for what they are and the worth they bring, not for the stamp on their passport, the colour of their skin or the religion they practise."
Photo courtesy University of Glasgow
Sheppard Robson, the architects behind the University of Liverpool’s Small Animal Teaching Hospital, have been celebrating this week after their design received a prestigious Royal Institute of British Architects (RIBA) North West Award.The Small Animal Teaching Hospital, located at the University’s Leahurst campus in Neston, was completed in 2007 and is considered to be one of the most advanced and complete animal veterinary facilities in the UK. It incorporates clinical services, undergraduate teaching and clinical research under one roof.The Royal Institute of British Architects (RIBA) annually presents regional awards for buildings that make a substantial contribution to the local environment and have high architectural standards.Ian Butler, Managing Partner at Sheppard Robson North, said: "The Small Animal Teaching Hospital at Liverpool University is a fantastic building. It is very strong and bold yet it is also simple and unfussy. It combines truly cutting edge teaching and research facilities with a sustainable building that blends into its environment. It is fantastic for our design to be lauded by RIBA. The Sheppard Robson team is very proud."The Small Animal Teaching Hospital, along with ten other North West buildings recognised by the regional judges, will now be considered for the National RIBA Awards in June.
kcs-intervet.swfIntervet / Schering-Plough Animal Health is running a challenge over the next few months to encourage the early diagnosis of Keratoconjunctivitis sicca (KCS), a painful disease which leads to permanent blindness (see right).
Practices are being asked to perform a Schirmer Tear Test (STT) on 50 dogs not previously diagnosed with KCS for the chance to win one of 70 Samsung digital cameras.
Recent studies¹ have shown the incidence of KCS to be 4.6% of the UK dog population, rising to 8.3% in predisposed breeds. However, 20 veterinary practices have recently participated in an Early Diagnosis Programme and the number confirmed with KCS was 9.7%². 17 of the cases diagnosed had Schirmer Tear Test readings of zero.
KCS is thought to be under-diagnosed because not all cases have the classic 'textbook' appearance but look surprisingly normal despite severely reduced tear production. In addition, diagnosis usually requires clinical suspicion and a Schirmer Tear Test.
Claudia Hartley, BVSc CertVOphthal DipECVO MRCVS, European Specialist in Veterinary Ophthalmology believes that: "All sore eyes (except where a descemetocoele is present) should have a Schirmer Tear Test, whether or not there is corneal change."
Melanie Dass MA VetMB CertSAM MRCVS ACIM, Product Manager for Optimmune said: "The results of our Early Diagnosis Programme made interesting reading and supported what we have always suspected - that KCS is under-diagnosed. It's really important that dogs suffering from this disease are detected promptly as early diagnosis and treatment with Optimmune gives the best prognosis.
"As part of the Early Diagnosis Programme owners of predisposed breeds received a personalised mailing offering them a free Schirmer Tear Test and some practices also elected to test all breeds at routine consultations such as vaccination. The tests were generally performed by veterinary nurses after they had received training, with the diagnosis made by a veterinary surgeon."
For more information about KCS, Optimmune and support in implementing an Early Diagnosis Programme, please contact your local Intervet / Schering-Plough Animal Health Territory Manager or call 01908 685685.
References¹ Pierce V & Williams D, 2006. Determination of Schirmer Tear Tests values in 1000 dogs. BSAVA Abstract 2006.² Intervet / Schering-Plough Animal Health Practices Study 2009
Vets Now has announced its selection centre dates for young vets applying for a place on the new 'Cutting Edge' Emergency and Critical Care fast track programme.
With the 20 August deadline for applications fast approaching, Vets Now has confirmed that interviews for the first intake in October will take place on 25th and 26th August. Applications received after this date will be considered only if the applicant meets the necessary criteria and is able to take up a place on the programme if extra places become available.
According to the company, the 'Cutting Edge' initiative is the first training programme of its kind in the UK. It'll see 40 vets who are likely to have graduated between 2006 and 2009 selected for a place on one of two 10 week fast track training programmes which will take them straight to the heart of emergency, working as a veterinary surgeon in a Vets Now clinic.
The induction courses will be held in October and January, each taking up to 20 vets through 10 weeks of intensive ECC training on a robust programme which has been designed by Vets Now Clinical Director and ECC Diplomate, Amanda Boag.
Amanda said: "The recruits who we select will embark upon an intensive period of training over the 10 week period which will give them the necessary skills and knowledge to launch their career in ECC. They will also receive ongoing support during their first two years as a Veterinary Surgeon in a Vets Now clinic with a very generous CPD allowance. The initial 10 week period will be a combination of lectures and interactive seminars, practical training in our clinical skills laboratory and mentored work in our clinics. Developing clinical expertise and problem solving skills will clearly be the most significant component of the training but there will also be support and training in other vital skills including communication."
She added: "Initial response to the programme has been very promising and we are delighted to see so many veterinary surgeons interested in developing their career in ECC."
Vets Now will continue to accept applications for the January intake to the 'Cutting Edge' programme throughout September and October.
Graduates who are interested in applying for a place on the 'Cutting Edge' training programme should contact the Vets Now recruitment team on 01383 841181 or email cuttingedge@vets-now.com
Dechra has launched a new support package to help veterinary surgeons and nurses dealing with otitis externa, and to encourage compliance amongst owners whose dogs are being treated for the disease.
Called the Dermatology Partners in Practice programme, the initiative includes a client compliance pack which contains the Guide to Good Ear Care, a leaflet on handling techniques, a treatment diary and a consultation report.
Roger Brown, Senior Brand Manager at Dechra Veterinary Products, said: "We are committed to supporting vets and vet nurses as they deal with cases of otitis externa at a time when responsible use of antimicrobials is in the spotlight.
"It is essential that owners comply with treatment programmes and that vets are supported with involving owners, which can lead to better outcomes for dogs receiving treatment and can be good for developing the practice business as well.
"We know from our research, and from talking to the vets and vet nurses, that owner compliance can be a barrier to successful first-time management and resolution of otitis externa.
"The new Client Compliance Pack is designed to support veterinary professionals as they diagnose, control and maintain this complex condition."
"All in all, it will provide extra support to the owner as they carry through the professional treatment plan once back home."
Veterinary surgeons are being invited to arrange a Business Support Discussion to find out more about the Dermatology Partners in Practice Programme and how it can benefit their practice. For details and to know more about the pack, call 01939 211215 or visit dechra.co.uk/timetochange.
The map gives an overview of the regulation applying to virtual care in different countries and it shows how virtual veterinary care is regulated predominantly in Western European countries only.
For the countries where veterinary virtual care is subject to regulation, the new map shows which countries:
https://vvca.org/resources/europe
Genitrix has announced that HY-50 Vet®, a sodium hyaluronate treatment for equine joints, has now been authorised for intravenous (IV) use.
Available until now for intra-articular (IA) use only, the company says HY-50 delivers the highest concentration of sodium hyaluronate on the market for the treatment of non-infectious joint inflammation and the enhancement of joint function.
Genitrix also says that, as IV application requires less specialist preparation than IA, HY-50 is now a practical solution for mixed practices with a smaller equine case load. Injected intravenously, the product will also benefit horses with multiple joint injuries.
HY-50 is presented in a 3 ml pre-loaded syringe, delivering 50 mg of sodium hyaluronate. It costs £55.50.
Rob Watkins, Marketing Director of Genitrix, said: "The efficacy of sodium hyaluronate is well established and we're delighted to be able to offer the IV route of administration. We know it will meet a real need in the market for a lameness treatment which is proven and simple to administer."
"Perhaps most importantly, in these financially difficult times, the high concentration of the product makes it a cost-effective approach compared with competitive products. We believe it will offer an affordable treatment option for owners who are anxious to treat their horses but may be discouraged by the high cost of many treatments."
For further information, see http://www.genitrix.co.uk/ or ring 01403 786345.
The new facilities use teaching aids and models to allow students to refine their practical skills and build confidence before being let loose on real patients.
As part of the official opening, Princess Anne toured the School of Veterinary Medicine, where she met with staff and students and saw a demonstration of a new equine gut model that offers an alternative to using live animals for research into the gut microbiota of horses and how they are affected by diet, disease and medication.
Professor Chris Proudman, Head of the School of Veterinary Medicine, said: "We are honoured to welcome The Princess Royal to the Vet School today, and very grateful that Her Royal Highness has officially opened the Large Animal Clinical Skills Facilities. Preparing students for life as a vet is our number one priority; the hands-on experience they will get through the use of this facility is invaluable and enables them to give the best possible care to all animals.
"We are also very grateful to the Longhurst family, without whom these teaching resources would not have been possible – their generosity is helping us to teach the vets of the future."
In response to growing demand for graduates equipped for a wide range of careers in veterinary and biomedical science, the Royal Veterinary College (RVC) has developed the BSc (Hons) course in Bioveterinary Sciences.
The Bioveterinary Science degree supersedes the BSc Veterinary Sciences that has been offered by RVC since 2002. Graduates go on to pursue careers within the biotechnology and pharmaceutical industries, veterinary-related professions, and biomedical research.
Prospective students interested in finding out more about the course are invited to attend an open day on Wednesday March 12 at the Camden Campus in London. Members of staff will be on hand to discuss aspects of the BSc in Bioveterinary Sciences degree, including entrance requirements and teaching and research facilities. In addition, current students will lead a tour of the London campus and talk about student life at the College. Further information and an online booking form can be found at http://www.rvc.ac.uk/
bank.wmv
Yes, the rather nattily dressed man pushing the trolley is, in another life, the editor of this site.
Long story.
Bayer Animal Health is to hold a free webinar for companion animal veterinary surgeons about its new fluoroquinolone for cats and dogs, Veraflox.
The one-hour webinar begins with a talk on mutant prevention concentration (MPC) from Dr Joe Blondeau, head of clinical microbiology at the Royal University Hospital & the Saskatoon Health Region, in Canada. He's followed by Dr E Bensignor, President of the European College of Veterinary Dermatology, who will present the findings of clinical studies. The final presentation by Dr Joy Olsen, global veterinary services manager for Bayer Animal Health, reviews the features and characteristics of Veraflox (pradofloxacin) and its use in cats and dogs.
The webinar can be watched live on Tuesday 25 October at 7:30pm, when you'll have the opportunity to put questions to the speakers. Alternatively, a recording of the event can be viewed at any point afterwards.
To register, visit http://nl.webcast3.animalhealth.be/nl/english-subscription#ht=944, to receive a login name and password.
For further information on Veraflox, contact your Bayer representative or call 01635 563000.
The British Veterinary Association has launched a survey of its members: "Your BVA, Your Say".
The focus of the research, which will take place throughout June and July, is to measure and evaluate the levels of satisfaction BVA members have with the Association and examining the value members place on BVA's representative role and benefits package.
A selection of members will be contacted by the external research agency Research by Design to take part in in-depth interviews to explore key themes of the research. Members who are currently practising and those in their final year at veterinary school will then be asked to complete an online survey.
Ahead of the research BVA is urging members to check that the Association has their most up-to-date contact details by visiting the member area of the website www.bva.co.uk/member or contacting the membership team on 020 7908 6350.
The results of the research will be used to develop and adapt BVA member services, activity and communication to ensure the Association meets members' requirements throughout their careers.
BVA President Carl Padgett said: "Our members are at the heart of everything we do, so it is essential we hear directly what our members think about, and want from, their Association.
"I'd like to encourage members to find time to contribute their ideas and opinions which will shape the future direction of the BVA. This is the chance to really make a difference to the Association."
CarefreeCredit, the loan company set up by Somerset vet Stewart Halperin so that practices can offer their clients interest free loans to cover emergency veterinary treatment, has embarked on a national PR campaign to raise awareness amongst pet owners about the service.
First out of the stalls was the Sunday Express, which covered the story last weekend. Further coverage is expected in other national newspapers over the coming few weeks.
CarefreeCredit provides loans from £250 to £25,000 for use against any veterinary bills. Credit terms offered by CarefreeCredit-enrolled veterinary practices, of which there are now more than 700, are normally 0% over 12 months or 9.9% over 24 months.
Practices pay £10 per month to enrol with CarefreeCredit, plus a small percentage of the amount of each loan made.
Stewart said: “Most vets usually end up discounting their invoices to enable pets to receive the treatment they desperately need when their owners aren’t insured and can’t afford to pay a large bill all at once. With CarefreeCredit, the owner doesn’t have to worry about paying the bill, the pet gets the treatment it needs and the vet is paid immediately and doesn’t have to worry about bad debts. Experience with this type of finance in the US shows that the average vet can reduce his debtors by up to 60%, improving his cash flow, while increasing his turnover by up to 22% per annum, so everyone’s a winner!”
For further information about offering CarefreeCredit to your clients, visit: http://www.carefreecredit.co.uk.
A 3 km Protection Zone and a 10 km Surveillance Zone have been put in place around the infected premises to limit the risk of the disease spreading.
The flock is estimated to contain approximately 35 birds. A number have died and the remaining live birds at the premises are being humanely culled.
A full investigation is under way to determine the source of the infection.
Keepers are urged to continue to be vigilant and look out for the signs of avian flu in their flocks, informing the Animal and Plant Health Agency should they suspect infection.
The company points to the well-known veterinary mental health and suicide stats, such as the study by the American Veterinary Medical Association, carried out on 12,000 veterinarians in the U.S. from 1979 to 2015, which found that vets are 3.5 times more likely to commit suicide than the general population.
The company says the new website offers personalised self-care formulas to help veterinary professionals counteract the stress derived from their work.
There are three sections: Emotional Health (Vet Voices), Vet Yogi and Eat Well Vet.
The content is a little thin at the moment, more of a consommé than a thick leek and potato, but no doubt more will be added over time.
For more information, visit https://www.happyvetproject.com
The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”
Sogeval has launched Efex, a marbofloxacin tablet designed for veterinary use.
Efex tablets are available in three blister pack sizes of 10mg, 40mg and 100mg that break into halves for cats and halves and quarters for dogs, facilitating accurate dosing for a wide range of patients.
In cats, the flavoured chewable 10 mg tablets allow accurate dosing of 2.5kg and 5kg cats at 2mg/kg once daily. In dogs the 40mg four way break tablet is designed for a 20 kg dog and the 100mg for a 50kg dog.
Efex tablets are chewable and sogeval says that in a palatability study 7 out of 10 cats readily consumed them.
Each tablet contains a broad-spectrum fluoroquinolone antibiotic marbofloxacin for oral administration, which is readily absorbed reaching maximal plasma concentrations within two hours. It exhibits a wide range of activity against gram-negative and gram-positive bacteria, including Pseudomonas spp and Mycoplasma spp.